bicalutamide and taxane

bicalutamide has been researched along with taxane in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhat-Nakshatri, P; Cheng, L; DeGrado, T; Gokmen-Polar, Y; Hutchins, GD; Jayaprakasan, V; Kelich, S; Miller, KD; Miller, MA; Nakshatri, H; Shanmugam, R; Sledge, GW; Sweeney, CJ; Yip-Schneider, M; Zheng, QH	1
Abrahamsson, PA; Chen, B; Chen, SY; Dizeyi, N; Semenas, J; Tinzl, M	1

Other Studies

2 other study(ies) available for bicalutamide and taxane

Article	Year
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model. The Prostate, 2006, Oct-01, Volume: 66, Issue:14 Topics: Androgen Antagonists; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Bridged-Ring Compounds; Cell Line, Tumor; Docetaxel; Drug Synergism; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Nitriles; Prostatic Neoplasms; Radionuclide Imaging; Sesquiterpenes; Taxoids; TNF Receptor-Associated Factor 1; TNF Receptor-Associated Factor 2; Tosyl Compounds; Umbilical Veins; Vascular Endothelial Growth Factor A	2006
Interaction between c-jun and androgen receptor determines the outcome of taxane therapy in castration resistant prostate cancer. PloS one, 2013, Volume: 8, Issue:11 Topics: Anilides; Animals; Apoptosis; Bridged-Ring Compounds; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flow Cytometry; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Nitriles; Prostatic Neoplasms; Protein Binding; Proto-Oncogene Proteins c-jun; Real-Time Polymerase Chain Reaction; Receptors, Androgen; RNA, Small Interfering; Taxoids; Tosyl Compounds	2013

Article

Year

Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model.

The Prostate, 2006, Oct-01, Volume: 66, Issue:14

Topics: Androgen Antagonists; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Bridged-Ring Compounds; Cell Line, Tumor; Docetaxel; Drug Synergism; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Nitriles; Prostatic Neoplasms; Radionuclide Imaging; Sesquiterpenes; Taxoids; TNF Receptor-Associated Factor 1; TNF Receptor-Associated Factor 2; Tosyl Compounds; Umbilical Veins; Vascular Endothelial Growth Factor A

2006

Interaction between c-jun and androgen receptor determines the outcome of taxane therapy in castration resistant prostate cancer.

PloS one, 2013, Volume: 8, Issue:11

Topics: Anilides; Animals; Apoptosis; Bridged-Ring Compounds; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flow Cytometry; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Nitriles; Prostatic Neoplasms; Protein Binding; Proto-Oncogene Proteins c-jun; Real-Time Polymerase Chain Reaction; Receptors, Androgen; RNA, Small Interfering; Taxoids; Tosyl Compounds

2013